Beta-Blockers May Enhance Immunotherapy for Melanoma – Medscape
|
Beta-Blockers May Enhance Immunotherapy for Melanoma
Medscape Specifically, among 195 patients with metastatic melanoma who were treated with immunotherapy (interleukin-2, cytotoxic t-lymphocyte associated protein 4, and/or programmed cell death-1 agents) between 2000 and 2015, the 5-year overall survival rate … |
